NPPB and diabetes mellitus: Under a targeted approach to diagnosis and management, patients with comorbidities such as diabetes, chronic kidney disease, or lab abnormalities such as BNP elevation, may be candidates for future clinical trials or novel medication classes without complex diagnostic evaluation.